Clinical Trials
4 trialsNCT07192471 2026-04-20
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
Kyowa Kirin Co., Ltd.
Phase 1 Not yet recruiting
NCT07529405 2026-04-14
CurbMF
Virogen Biotechnology Inc.
Phase 2 Not yet recruiting
NCT07213882 2025-10-09
CITY
Assistance Publique - Hôpitaux de Paris
Phase EARLY_PHASE1 Not yet recruiting
NCT05205902 2022-01-25
TOTEM-01
Assistance Publique - Hôpitaux de Paris
Phase 3 Not yet recruiting